You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Pulmonary Arterial Hypertension Management Master Class: Quickfire Cases

  • Authors: Oksana A. Shlobin, MD, FCCP; Jean M. Elwing, MD, FCCP; Lana Melendres-Groves, MD; Steven D. Nathan, MD, FCCP
  • CME Released: 11/3/2023
  • Valid for credit through: 11/3/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for cardiologists, pulmonologists, primary care physicians (PCPs), nurse practitioners (NPs), physician assistants (PAs), and other healthcare providers (HCPs) involved in the care of patients with pulmonary hypertension (PH).

The goal of this activity is for learners to be better able to improve integration of the latest advances in PAH care to optimize patient management across the spectrum of disease for clinically confounding cases.

Upon completion of this activity, participants will:

  • Have greater competence related to
    • Assessing risk to enhance PAH disease management
    • Selecting a treatment approach for patients with PAH across the spectrum of disease
  • Demonstrate greater confidence in their ability to
    • Diagnose and manage PAH across the disease spectrum


Disclosures

Medscape, LLC and Albert Einstein College of Medicine-Montefiore Medical Center requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape and Albert Einstein College of Medicine-Montefiore Medical Center policies. Others involved in the planning of this activity have no relevant financial relationships.


Chairperson

  • Oksana A. Shlobin, MD, FCCP

    Associate Professor
    Georgetown University School of Medicine
    University of Virginia School of Medicine
    Medical Director
    Pulmonary Hypertension Program
    Director of Education
    Advanced Lung Disease and Transplant Program
    Inova Fairfax Hospital
    Falls Church, Virginia

    Disclosures

    Oksana A. Shlobin, MD, FCCP, has the following relevant financial relationships:
    Consultant or advisor for: Aerami; Aerovate; Janssen Biotech, Inc.; Merck; Enzyvant; United Therapeutics Corporation
    Speaker or member of speakers bureau for: Bayer; Janssen Biotech, Inc.; United Therapeutics Corporation

Speakers

  • Jean M. Elwing, MD, FCCP

    Professor of Medicine
    Director, Pulmonary Hypertension Program
    University of Cincinnati
    Cincinnati, Ohio

    Disclosures

    Jean M. Elwing, MD, FCCP, has the following relevant financial relationships:
    Consultant or advisor for: Acceleron Pharma, Inc.; Aerovate (former); Altavant (former); Bayer; Gossamer Bio (former); Insmed Incorporated (former); Janssen Biotech, Inc.; Merck; Liquidia; United Therapeutics Corporation
    Speaker or member of speakers bureau for: United Therapeutics Corporation
    Research funding from: Acceleron Pharma, Inc.; Aerovate; Actelion Pharmaceuticals, Ltd; Altavant; Bayer; Gossamer Bio; Janssen Biotech, Inc.; Lung LLC; Merck; Pharmosa; Phase Bio; Tenax; United Therapeutics Corporation

  • Lana Melendres-Groves, MD

    Assistant Dean, Office of Faculty Affairs and Career Development
    Vice Chair Diversity, Equity, and Inclusion Dept of Medicine
    Professor, Dept of Internal Medicine
    Medical Director, Clinical Trial Unit, DoIM
    Medical Director, Pulmonary Hypertension Program
    Pulmonary & Critical Care Division
    University of New Mexico
    Albuquerque, New Mexico

    Disclosures

    Lana Melendres-Groves, MD, has the following relevant financial relationships:
    Consultant or advisor for: Bayer; Janssen Biotech, Inc.; Merck; United Therapeutics Corporation
    Speaker or member of speakers bureau for: Bayer; Janssen Biotech, Inc.; United Therapeutics Corporation
    Research funding from: Bayer; Janssen Biotech, Inc.; Merck; United Therapeutics Corporation

  • Steven D. Nathan, MD, FCCP

    Medical Director
    Advanced Lung Disease and Transplant Program
    Inova Fairfax Hospital
    Falls Church, Virginia

    Disclosures

    Steven D. Nathan, MD, FCCP, has the following relevant financial relationships:
    Consultant or advisor for: Avalyn; Bellerophon Therapeutics; Boehringer Ingelheim Pharmaceuticals, Inc.; Insmed Incorporated; Merck; Pliant; Roche; Roivant; United Therapeutics Corporation
    Speaker or member of speakers bureau for: Boehringer Ingelheim Pharmaceuticals, Inc.; United Therapeutics Corporation
    Research funding from: Tvardi
    Contracted researcher for: Tvardi; United Therapeutics Corporation
    Owns stock (publicly traded) in: Merck; Pfizer, Inc.

Editor

  • George Boutsalis, PhD

    Senior Director, Content Development, Medscape, LLC

    Disclosures

    George Boutsalis, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Content Reviewer

This activity has been peer reviewed in its entirety, for bias and objectivity, by reviewers that have no relevant financial relationships in the last 24 months prior to the activity. The authors of this activity provided educational content and resources in advance, as we requested. All their recommendations for patient care were made based on current science, evidence, and clinical reasoning, while giving a fair and balanced view of unbiased diagnostic and therapeutic options.

Sandhya Murthy, MD
Content Reviewer, Montefiore Medical Center
Sandhya Murthy, MD, has no relevant financial relationships


Accreditation Statements

Developed through a partnership between Medscape Education and Albert Einstein College of Medicine-Montefiore Medical Center.

Montefiore

In support of improving patient care, Albert Einstein College of Medicine -Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Pulmonary Arterial Hypertension Management Master Class: Quickfire Cases

Authors: Oksana A. Shlobin, MD, FCCP; Jean M. Elwing, MD, FCCP; Lana Melendres-Groves, MD; Steven D. Nathan, MD, FCCPFaculty and Disclosures

CME Released: 11/3/2023

Valid for credit through: 11/3/2024, 11:59 PM EST

processing....

Educational Impact Challenge

Please answer the questions below to self-assess your knowledge. Answering these questions again after the activity will allow you to see what you learned.

  • Print